Trial Showed that Resolaris Improved Muscle Strength in FSHD Patients
What are medical communities doing about it?
Medical communities never accept chronic conditions and do nothing about it, for that reason studies and researches are always targeting the development of innovative therapies, such is the case of this state of the art therapy created by aTyr Pharma which was presented at the 22nd International Congress of the World Muscle Society (WMS) in France. This is where Resolaris first began to come into play, a drug that is currently in trial and at its halfway mark.